HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prevalence and treatment of anemia in critically ill patients].

Abstract
Anemia is a common condition among medical and surgical patients admitted to the intensive care unit (ICU) and generally has a multifactorial origin. In order to avoid the deleterious effects of anemia, 40% of ICU patients receive allogenic blood transfusion (ABT). This figure increases up to 70% if the ICU stay is longer than 7 days. However, ABT is associated with a dose-dependent increase in morbidity and mortality. In contrast, the administration of exogenous erythropoietin plus iron supplements, especially iv iron, improves anemia and reduces ABT requirements, although it does not reduce mortality. To ascertain whether treatment of anemia in the critically ill with exogenous erythropoietin and iron might improve outcomes and to optimize drug administration schedules and dosage, further studies with sufficient statistical power and adequate follow-up are warranted.
AuthorsM Muñoz, S R Leal-Noval, J A García-Erce, E Naveira
JournalMedicina intensiva (Med Intensiva) Vol. 31 Issue 7 Pg. 388-98 (Oct 2007) ISSN: 0210-5691 [Print] Spain
Vernacular TitlePrevalencia y tratamiento de la anemiaen el paciente crítico.
PMID17942062 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Recombinant Proteins
  • Erythropoietin
  • Iron
Topics
  • Anemia (epidemiology, etiology, therapy)
  • Blood Transfusion
  • Critical Illness
  • Erythropoiesis
  • Erythropoietin (therapeutic use)
  • Humans
  • Injections, Intravenous
  • Iron (administration & dosage)
  • Prevalence
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: